Amplatzer Talisman
Payments companies reported to CMS as associated with Amplatzer Talisman. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Amplatzer Talisman, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Amplatzer Talisman
These are the largest totals companies reported as associated with Amplatzer Talisman. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Samuel Turner | Winston Salem, NC | Interventional Cardiology | $38,341.32 |
| Mark Gajjar | Kyle, TX | Interventional Cardiology | $31,913.87 |
| Thomas Forbes | Detroit, MI | Pediatric Cardiology | $26,368.32 |
| Amir Ashrafi | Atlanta, GA | Pediatrics | $26,108.88 |
| Jeffrey Delaney | Durham, NC | Pediatric Cardiology | $24,731.06 |
| John Lasala | Saint Louis, MO | Interventional Cardiology | $23,863.21 |
| James Jenkins | New Orleans, LA | Interventional Cardiology | $21,467.39 |
| Jason Day | Oak Lawn, IL | Vascular Neurology | $19,644.41 |
| Fahad Gilani | Manchester, NH | Cardiovascular Disease | $18,517.74 |
| Dhaval Parekh | Houston, TX | Interventional Cardiology | $18,490.88 |
Prescribed Amplatzer Talisman?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.